SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-105369
Filing Date
2013-03-13
Accepted
2013-03-13 16:53:28
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d444102d10k.htm 10-K 1509182
2 EX-23.1 d444102dex231.htm EX-23.1 1555
3 EX-31.1 d444102dex311.htm EX-31.1 6576
4 EX-31.2 d444102dex312.htm EX-31.2 6584
5 EX-32.1 d444102dex321.htm EX-32.1 3495
6 EX-32.2 d444102dex322.htm EX-32.2 3508
13 GRAPHIC g444102g01i56.jpg GRAPHIC 36997
14 GRAPHIC g444102g09q22.jpg GRAPHIC 40338
  Complete submission text file 0001193125-13-105369.txt   8481321

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tsrx-20121231.xml EX-101.INS 1229583
8 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20121231.xsd EX-101.SCH 74701
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20121231_cal.xml EX-101.CAL 69825
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsrx-20121231_def.xml EX-101.DEF 250804
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20121231_lab.xml EX-101.LAB 545713
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20121231_pre.xml EX-101.PRE 409057
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34828 | Film No.: 13687940
SIC: 2834 Pharmaceutical Preparations